Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.43 |
| ▸ | MMP9 | P14780 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 5/20 | 0.42 |
| ▸ | CA1 | P00915 | 4/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.37 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.37 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | GGT1 | P19440 | 1/20 | 0.35 |
| ▸ | BMP1 | P13497 | 1/20 | 0.33 |
| ▸ | GGH | Q92820 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL4587284 | 0.88 | KMT2A (0.46) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL6554061 | 0.85 | KMT2A (0.47) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL21802287 | 0.85 | KMT2A (0.47) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL3651670 | 0.85 | FOLH1 (0.53) | MMP9FOLH1RIMKLANAALAD2GGH | |
| Cysteine SCHEMBL4586359 | 0.83 | KMT2A (0.41) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL2177303 | 0.83 | KMT2A (0.45) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL28142279 | 0.83 | KMT2A (0.45) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL8768913 | 0.82 | KMT2A (0.48) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL8768917 | 0.82 | KMT2A (0.48) | KMT2AALOX15BLMPMP22MMP2 | |
| SCHEMBL4397483 | 0.81 | KMT2A (0.44) | KMT2AALOX15BLMPMP22MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4163383-A1 | MICROBIAL PRODUCTION OF FATTY AMINES | Genomatica, Inc. (US) | 2023-04-12 | — | — | EP | disclosed |
| EP-3647430-B1 | MICROBIAL PRODUCTION OF FATTY AMINES | GENOMATICA INC (US) | 2022-10-26 | — | — | EP | disclosed |
| CN-115151636-A | Engineered erythroid cells comprising HLA-G polypeptides and methods of use thereof | 鲁比厄斯治疗法股份有限公司 | 2022-10-04 | — | — | CN | disclosed |
| US-8378071-B2 | Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2013-02-19 | — | — | US | disclosed |
| US-20090247467-A1 | PEPTIDE EPITOPES OF VEGFR-2/KDR THAT INHIBIT ANGIOGENESIS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF | 2009-10-01 | — | — | US | disclosed |
| US-20060234941-A1 | Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis | THE GOV. OF THE USA AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES | 2006-10-19 | — | — | US | disclosed |
| US-20060088509-A1 | Isolated clk-1 -/- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders | MCGILL UNIVERSITY (CA) | 2006-04-27 | — | — | US | disclosed |
| WO-2006037224-A1 | ISOLATED CLK-1 -I- CELLS FROM CLK-1 HETEROZYGOUS ANIMALS AND THEIR USE IN TREATING OXIDATIVE STRESS DISORDERS | MCGILL UNIVERSITY (CA) | 2006-04-13 | — | — | WO | disclosed |
| CN-1460109-A | Improved specificity in treatment of diseases | RIBA PHARMACEUTICALS INC (US) | 2003-12-03 | — | — | CN | disclosed |
| WO-2002031123-A1 | STEM CELLS | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2002-04-18 | — | — | WO | disclosed |
| US-6228589-B1 | MONITORING POISONING; INCUBATE ANIMAL WITH MODULATOR, EXTRACT MESSENGER NUCLEIC ACIDS, FORMING COMPLEMENTARY DEOXYRIBONUCLEIC ACIDS, SEQUENCE NUCLEOTIDE SEQUENCE AND MONITOR FREQUENCY DISTRIBUTION OF EXPRESSED GENES | LYNX THERAPEUTICS, INC. | 2001-05-08 | — | — | US | disclosed |